Related Experiment Video
Updated: Dec 28, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and
Sara B Salazar1, Rita S Simões1, Nuno A Pedro1
1Department of Bioengineering, Institute of Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.
Abstract:
Fungal infections and, in particular, those caused by species of the Candida genus, are growing at an alarming rate and have high associated rates of mortality and morbidity. These infections, generally referred as candidiasis, range from common superficial rushes caused by an overgrowth of the yeasts in mucosal surfaces to life-threatening disseminated mycoses. The success of currently used antifungal drugs to treat candidiasis is being endangered by the continuous emergence of resistant strains, specially among non-albicans Candida species. In this review article, the mechanisms of action of currently used antifungals, with emphasis on the mechanisms of resistance reported in clinical isolates, are reviewed. Novel approaches being taken to successfully inhibit growth of pathogenic Candida species, in particular those based on the exploration of natural or synthetic chemicals or on the activity of live probiotics, are also reviewed. It is expected that these novel approaches, either used alone or in combination with traditional antifungals, may contribute to foster the identification of novel anti-Candida therapies.
Insights
Emerging antifungal resistance in Candida infections necessitates new treatments. This review explores current antifungal drugs, resistance mechanisms, and novel therapies like natural compounds and probiotics to combat candidiasis.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Fungal infections caused by Candida species are increasing, leading to significant mortality and morbidity.
- Candidiasis ranges from superficial to life-threatening disseminated forms.
- Emergence of antifungal resistance, especially in non-albicans Candida, threatens current treatment efficacy.
Purpose of the Study:
- To review the mechanisms of action of existing antifungal drugs.
- To highlight resistance mechanisms in clinical Candida isolates.
- To explore novel therapeutic strategies against pathogenic Candida species.
Main Methods:
- Literature review of antifungal mechanisms and resistance.
- Analysis of emerging therapeutic approaches, including natural products and probiotics.
- Synthesis of information on current and novel anti-Candida therapies.
Main Results:
- Current antifungals face challenges due to widespread resistance.
- Mechanisms of resistance in clinical isolates are diverse.
- Novel approaches involving natural/synthetic chemicals and probiotics show promise.
Conclusions:
- Novel therapies, alone or combined with traditional antifungals, may offer new solutions.
- Further research into these novel approaches is crucial for developing effective anti-Candida treatments.
- Addressing antifungal resistance is critical for managing Candida infections.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Treatment Resistant Cancers
Antimicrobial Effectiveness
Combined Effects of Drugs: Synergism
Such synergistic combinations...

